Fundz

Immunome Appoints Roee Shahar as Executive Vice President, Commercial

PUBLIC · IMNMOct 08, 2024

Position

Vice President

Company

Immunome Inc.

Roee Shahar
rshahar@immunome.com
BothellBiotechnologyHealth CareMedicalTherapeutics

Description

Immunome, Inc. appoints Roee Shahar as Executive Vice President, Commercial, to advance a portfolio of targeted oncology agents, particularly AL102, a gamma secretase inhibitor currently in a Phase 3 trial for treatment of desmoid tumors.

Quick answer

Immunome Appoints Roee Shahar as Executive Vice President, Commercial (October 8, 2024). Immunome Inc. is based in Bothell, Washington, United States.

Who is the new Vice President at Immunome Inc?
Immunome Inc. named Roee Shahar Vice President, announced October 8, 2024.
What did Immunome Inc. announce on October 8, 2024?
Immunome, Inc. appoints Roee Shahar as Executive Vice President, Commercial, to advance a portfolio of targeted oncology agents, particularly AL102, a gamma secretase inhibitor currently in a Phase 3 trial for treatment of desmoid tumors.
What does Immunome Inc. do?
Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies.
Where is Immunome Inc. based?
Immunome Inc. is based in Bothell, Washington, United States.
Which similar companies made leadership changes around the same time?
Aethlon Medical (October 3, 2024), Adverum Biotechnologies (October 17, 2024), Parexel (October 22, 2024) and Actinogen Medical (October 29, 2024) also announced leadership changes within 45 days of Immunome Inc.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Immunome Inc., and when

A new leader at Immunome Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Immunome Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Immunome Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immunome Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immunome Inc.

Location

665 STOCKTON DRIVE

Bothell, Washington, United States

About

Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies. Our portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, targeted effectors, radioligand therapies and antibody drug conjugates (ADCs). We believe that pursuing underexplored targets with appropriate drug modalities leads to transformative therapies. Our proprietary memory B cell hybridoma technology allows for the rapid screening and functional characterization of novel antibodies and targets. Immunome is proud to be an Equal Employment Opportunity employer. We do not discriminate based upon race, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, or other applicable legally protected characteristics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immunome Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Bob
Likely contact at this company
••••••••@••••••••

See Bob's verified email →

Roee
Likely contact at this company
••••••••@••••••••

See Roee's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Immunome Inc.'s next move

Learn about Strategic plan

Immunome Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.